You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pf-06463922

Showing 1 - 5 of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Worldwide (Avelumab, PF-06463922, Crizotinib)

Active, not recruiting
Has Results
  • Non-Small Cell Lung Cancer
  • Atlanta, Georgia
  • +20 more
Jan 13, 2022

ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC Trial in Worldwide (PF-06463922, Crizotinib)

Active, not recruiting
Has Results
  • ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC
  • Fayetteville, Arkansas
  • +71 more
Feb 16, 2022

Healthy Trial in New Haven (PF-06463922, rifampin)

Completed
Has Results
  • Healthy
  • New Haven, Connecticut
    Pfizer New Haven Clinical Research Unit
Aug 22, 2018

Healthy Trial in Brussels (PF-06463922, Itraconazole)

Completed
  • Healthy
  • Brussels, Belgium
    Pfizer Clinical Research Unit
May 12, 2017

Healthy Trial in Brussels (PF-06463922, rabeprazole)

Completed
  • Healthy
  • Brussels, Belgium
    Pfizer Clinical Research Unit
May 13, 2016